Supporting biologic-based drug discovery and development for nervous system disorders through preclinical research, Phase I trials, and collaboration with NIH consultants and CROs.
This NIH program supports researchers in developing small-molecule neurotherapeutics by providing funding, expert guidance, and industry resources to advance drug candidates toward clinical testing.
NIH supports development, testing, and clinical feasibility studies of therapeutic and diagnostic devices for nervous or neuromuscular disorders through milestone-driven cooperative agreements.
NIH supports national biomedical imaging and bioengineering centers that develop research-driven technologies, share them with investigators, and train researchers in their use.
This limited competition funds continued operation of National Cancer Institute biospecimen banks supporting national, early-phase, and experimental cancer clinical trials and translational research.
NCI funds collaborative teams to develop therapies for adult glioblastoma that cross the blood-brain barrier, advancing novel or repurposed agents from preclinical studies into Phase 0/1 trials.